Anhui Huangshan Capsule Co., Ltd. (SHE:002817)

Market Cap	2.54B +34.7%
Revenue (ttm)	471.08M +3.8%
Net Income	57.77M +14.9%
EPS	0.18 +1.2%
Shares Out	299.10M
PE Ratio	47.17
Forward PE	n/a
Dividend	0.07 (0.84%)
Ex-Dividend Date	Dec 31, 2025

Volume	4,440,300
Average Volume	6,967,331
Open	8.34
Previous Close	8.45
Day's Range	8.34 - 8.54
52-Week Range	5.40 - 8.61
Beta	0.36
RSI	63.04
Earnings Date	Mar 21, 2026

About Anhui Huangshan Capsule

Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. It offers hypromellose empty capsules, pullulan empty capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl starch hollow capsules. The company was founded in 1989 and is headquartered in Xuancheng, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 681
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002817

Financial Performance

In 2024, Anhui Huangshan Capsule's revenue was 473.48 million, an increase of 2.31% compared to the previous year's 462.77 million. Earnings were 49.25 million, a decrease of -24.07%.